7 min readUpdated
Dysport vs Botox: Units, Results and How to Choose
Dysport and Botox work the same way but are dosed differently. The unit conversion, what head-to-head trials found on onset, duration and spread, and which suits which area.

If you only read one thing
Dysport and Botox are both botulinum toxin type A and work the same way, but their units are not interchangeable: about 2.5 to 3 Dysport units equal one Botox unit. Dysport may start slightly sooner and tends to spread a little wider, which can suit a broad forehead, while Botox is FDA-approved for more areas, including crow's feet. Both usually last about three to four months.
- Dysport and Botox units are not interchangeable; a Botox-to-Dysport ratio of 1:2.5 to 1:3 gave comparable results in a systematic review.
- The labeled frown-line dose is 50 units of Dysport and 20 units of Botox Cosmetic.
- Dysport's median onset was 2 to 3 days across 42 upper-face studies; trials on which lasts longer point both ways.
- Dysport tends to spread wider at the usual ratio, which can suit the forehead; Botox is FDA-approved for crow's feet and the forehead.
- Dysport at KORA: $4.50 / unit. Botox: $13.50 / unit.
On this page 7 sections
Dysport vs Botox is a common question, usually from people who have seen two very different prices per unit. In this guide I explain what the FDA labels say about each product, how the unit conversion works, what head-to-head trials found on onset, duration and spread, and how to think about which one suits which area.
What is the same and what is different
Dysport (abobotulinumtoxinA) and Botox Cosmetic (onabotulinumtoxinA) are both botulinum toxin type A, and both soften lines by blocking the nerve signal to the muscle underneath. They are made by different companies with different manufacturing and potency tests, so a unit of one is not a unit of the other. Dysport’s label states that its units “cannot be compared to or converted into units of any other botulinum toxin products,” and the Botox Cosmetic label says the same in its own words.
Their FDA-approved cosmetic uses also differ. Dysport is approved for frown lines (the “11s”) in adults under 65, along with medical uses such as cervical dystonia and spasticity. Botox Cosmetic is approved for frown lines, forehead lines, crow’s feet and, since 2024, platysma bands in the neck. Using Dysport on the forehead or around the eyes is common and well studied, but it is off-label, and that is explained before treatment.
| Dysport | Botox Cosmetic | |
|---|---|---|
| FDA-approved cosmetic areas | Frown lines (adults under 65) | Frown lines, forehead lines, crow’s feet, platysma bands |
| Labeled frown-line dose | 50 units in 5 injections | 20 units in 5 injections |
| When it starts | Median 2 to 3 days across studies | Usually 1 to 2 days, building over the first week |
| How long it lasts (label) | Up to four months | About three to four months |
| Eyelid droop in frown-line trials | 2 percent | 3 percent |
The eyelid droop figures come from each product’s own trials and are not a head-to-head comparison, but they show that this side effect is uncommon with both.
How the unit conversion works
The working ratio most injectors use is about 2.5 to 3 units of Dysport for every unit of Botox. That is a clinical rule of thumb, not a figure on either label. A 2015 systematic review in Movement Disorders Clinical Practice by Dashtipour and colleagues looked at randomized trials comparing the two and concluded that a Botox-to-Dysport ratio “between 1:2.5 and 1:3.0 provides comparable safety and efficacy.” Ratios higher than 1:3 were linked to more side effects. Those trials were in neck and eyelid spasm, at much higher doses than cosmetic treatment, so the range is a guide and the dose is adjusted for each face.
This is why a straight comparison of price per unit is misleading. Dysport costs less per unit at KORA, but you need more of its units. The fair comparison is the total for the same treatment plan.
Onset and duration: what head-to-head trials found
Dysport may start slightly sooner, and the evidence on which lasts longer is mixed and depends on the dose ratio used. A 2020 systematic review in the Journal of Clinical and Aesthetic Dermatology by Nestor and colleagues gathered 42 studies of Dysport in the upper face and found a median onset of 2 to 3 days; in one trial, 55 percent of patients had a response by day 2. In a head-to-head study within that review, Dysport reached its effect about half a day faster than Botox. The review was sponsored by Ipsen, which makes Dysport.
On duration, the results point both ways:
- Favoring DysportIn a 2011 split-forehead study by Nestor and Ablon, 20 women had Dysport on one side and Botox on the other at a 2.5 to 1 ratio. Full effect lasted a median of 119 days with Dysport and 77 days with Botox.
- Favoring BotoxIn a 2006 randomized trial in the Journal of the American Academy of Dermatology by Lowe and colleagues, 62 patients received 20 units of Botox or 50 units of Dysport for frown lines. At 16 weeks, 53 percent of the Botox group still had at least a one-point improvement, compared with 28 percent of the Dysport group. That trial was manufacturer-supported.
My reading is that at the usual ratios both last roughly three to four months, and the ratio and the injector’s dosing make more difference than the brand. Your own timeline is covered in our Botox timeline guide.
Spread: why the area matters
At the usual conversion, Dysport tends to affect a wider area around each injection point than Botox. A 2025 split-face trial in Dermatology and Therapy by Bennek and colleagues measured the zone where sweating stopped, a standard proxy for toxin spread, after forehead injections at a fixed 1 to 2.5 ratio. The spread was largest with Dysport (about 62 square centimeters), then Botox (about 46), with a third toxin smallest. Wrinkle improvement was similar for all three. The study was small, 26 people finished it, and it was funded by the maker of the third product.
A wider field can be helpful on a broad, even muscle like the forehead, where it can smooth the area with fewer injection points. Close to the eye and brow, where a few millimeters decide whether a brow or lid drops, the effect should stay tight. Dilution and depth also change spread, so technique matters as much as the product.
Which suits which area
For most patients, both products work well, and the area being treated is what tips the choice.
- Frown linesBoth are FDA-approved here. This is the area with the most head-to-head data, and both perform well at their labeled doses.
- ForeheadBotox Cosmetic is FDA-approved for forehead lines; Dysport use here is off-label but common. A wider field can suit a broad forehead, as long as the brows are protected.
- Crow’s feetBotox Cosmetic is FDA-approved at 24 units. Dysport is off-label here, and tighter spread is an advantage next to the eye.
- Masseter or jawOff-label for both. See my Dysport vs Botox for the masseter guide.
- Over 65Dysport’s frown-line approval is for adults under 65. In its trials, none of the 8 patients aged 65 or older reached the success threshold, so if you are 65 or older, ask about this at your consultation.
What it costs at KORA
Dysport has the lower price per unit, but a plan needs about 2.5 to 3 times as many Dysport units, so compare totals for the same plan.
Dysport
Per unit$4.50 / unit
Botox
Per unit$13.50 / unit
Consultation
Assessment and planComplimentary
Prices come from our current price list. Your plan and total are confirmed at a complimentary consultation before anything begins.
Learn more about Dysport and Botox at our clinic on the Scottsdale and Paradise Valley border, or read how Xeomin compares with Botox.
DysportDysport in Scottsdale at KORA Aesthetics — $4.50 per unit, injected by a national clinical trainer for Galderma, the company that makes it. It spreads more than Botox, which suits broad forehead lines and crow's feet. See how the unit conversion works, why price per unit is not price per treatment, and when Dysport is the better choice.See treatment, prices and resultsFrequently asked questions
Is Dysport the same as Botox?
No. Both are botulinum toxin type A and work the same way, but they are made differently, dosed in different units and approved for different areas.
How many units of Dysport equal Botox?
Injectors commonly use about 2.5 to 3 Dysport units for each Botox unit. A systematic review found a ratio between 1:2.5 and 1:3 gave comparable results, but the labels say units cannot be converted, so your dose is set at the consultation.
Does Dysport kick in faster than Botox?
Possibly slightly. A 2020 review found a median onset of 2 to 3 days for Dysport, and one head-to-head study found it about half a day faster than Botox.
Which lasts longer, Dysport or Botox?
Studies disagree. One split-forehead study found Dysport lasted longer, while a randomized frown-line trial found Botox had more effect left at 16 weeks. At usual doses, both tend to last about three to four months.
Is Dysport cheaper than Botox?
Dysport costs less per unit, but you need more units. At KORA, Dysport is $4.50 / unit and Botox is $13.50 / unit, so compare the total for the same plan.
Is Dysport FDA-approved for the forehead and crow's feet?
No. Dysport is FDA-approved for frown lines in adults under 65. Its use on the forehead and around the eyes is off-label, while Botox Cosmetic is approved for both.
Can I switch from Botox to Dysport?
Yes. Switching is common, but the dose has to be recalculated, so tell your injector which product and how many units you had before.
Sources
- Ipsen Biopharmaceuticals. DYSPORT (abobotulinumtoxinA) prescribing information, revised 1/2023. U.S. Food and Drug Administration, 2023
- Allergan (AbbVie). BOTOX Cosmetic (onabotulinumtoxinA) prescribing information, revised 10/2024. AbbVie, 2024
- Dashtipour K, Chen JJ, Espay AJ, Mari Z, Ondo W. OnabotulinumtoxinA and abobotulinumtoxinA dose conversion: a systematic literature review. Movement Disorders Clinical Practice, 2015
- Nestor M, Cohen JL, Landau M, et al. Onset and duration of abobotulinumtoxinA for aesthetic use in the upper face: a systematic literature review. Journal of Clinical and Aesthetic Dermatology, 2020
- Lowe P, et al. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines. Journal of the American Academy of Dermatology, 2006 (summary in NEJM Journal Watch)
- Bennek M, Rudowitz D, Kerscher M. Diffusion characteristics of letibotulinumtoxinA, onabotulinumtoxinA and abobotulinumtoxinA: a randomized split-face clinical trial. Dermatology and Therapy, 2025




